Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection

This publication has 22 references indexed in Scilit:

• Discontinuation of prophylaxis for Pneumocystis carinii pneumonia in HIV-1-infected patients treated with highly active antiretroviral therapy
  The Lancet, 1999
• Changing patterns of mortality across Europe in patients infected with HIV-1
  The Lancet, 1998
• Changes in use of antiretroviral therapy in regions of Europe over time
  AIDS, 1998
• Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
  New England Journal of Medicine, 1998
• Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study
  BMJ, 1997
• Regional Differences in Use of Antiretroviral Agents and Primary Prophylaxis in 3122 European HIV-Infected Patients
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 1997
• Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres
  AIDS, 1997
• Impact of Combination Therapy for HIV Infection on Inpatient Census
  New England Journal of Medicine, 1997
• Decline in deaths from AIDS due to new antiretrovirals
  The Lancet, 1997
• A Controlled Trial of Trimethoprim–Sulfamethoxazole or Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis carinii Pneumonia in Patients with the Acquired Immunodeficiency Syndrome
  New England Journal of Medicine, 1992